Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Biomolecules|April 30, 2021
Inhibition of the Receptor for Advanced Glycation End Products Enhances the Cytotoxic Effect of Gemcitabine in Murine Pancreatic TumorsPriyanka Swami, Kelly A O'Connell, Swetha Thiyagarajan, et al.
Cancer Immunology, Immunotherapy : CII|December 6, 2017
Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumorsKamiya Mehla, Jarrod Tremayne, James A Grunkemeyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2011
Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-RasJohn P Eggers, Paul M Grandgenett, Eric C Collisson, et al.
The Journal of Experimental Medicine|July 2, 2025
Histidine decarboxylase inhibition attenuates cancer-associated muscle wastingAneesha Dasgupta, Rebecca E Schmitt, Tatsuyoshi Kono, et al.
Scientific Reports|February 1, 2022
Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signalingPauline C Xu, Mikyoung You, Seok-Yeong Yu, et al.
Cancer Letters|March 9, 2026
A MUC1-ALIX complex regulates extracellular vesicle cargo loading with activated SRC to enhance pancreatic cancer progressionYing Huang, Kristine V Hoagstrom, Clara S Mundry, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
AI-powered Deep Visual Proteomics reveals critical molecular transitions in pancreatic cancer precursorsJimin Min, Lisa Schweizer, Gijs Zonderland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2019
The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical ResponseHenry C-H Law, Dragana Lagundžin, Emalie J Clement, et al.
Molecular Cancer Therapeutics|February 23, 2024
Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6Eric N Aguilar, Satish Sagar, Brandy R Murray, et al.
Cancer Discovery|April 21, 2026
AI-powered Deep Visual Proteomics reveals critical molecular transitions in pancreatic cancer precursorsJimin Min, Lisa Schweizer, Gijs Zonderland, et al.
Pageof 4